(Q38293482)

1 September 2017

1 reference

title

HDL in infectious diseases and sepsis (English)

1 reference

1 September 2017

0 references

2

1 reference

PubMed ID

25522999

1 September 2017

Giuseppe Danilo Norata

object named as

Giuseppe Danilo Norata

series ordinal

3

0 references

Angela Pirillo

object named as

Angela Pirillo

series ordinal

1

0 references

publication date

1 January 2015

1 reference

Handbook of experimental pharmacology

1 September 2017

1 reference

1 September 2017

224

1 reference

1 September 2017

483-508

1 reference

Hepatitis C virus and other flaviviridae viruses enter cells via low density lipoprotein receptor

1 September 2017

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_15

Endothelial lipase is increased in vivo by inflammation in humans

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_15

Inflammation predicts changes in high-density lipoprotein particles and apolipoprotein A1 following initiation of antiretroviral therapy.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_15

High density lipoprotein cholesterol levels are an independent predictor of the progression of chronic kidney disease.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_15

Experimental therapy of African trypanosomiasis with a nanobody-conjugated human trypanolytic factor

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_15

Effects of torcetrapib in patients at high risk for coronary events

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_15

Cell entry of hepatitis C virus requires a set of co-receptors that include the CD81 tetraspanin and the SR-B1 scavenger receptor

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_15

An Interplay between Hypervariable Region 1 of the Hepatitis C Virus E2 Glycoprotein, the Scavenger Receptor BI, and High-Density Lipoprotein Promotes both Enhancement of Infection and Protection against Neutralizing Antibodies

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_15

The tissue pentraxin PTX3 limits C1q-mediated complement activation and phagocytosis of apoptotic cells by dendritic cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_15

Apolipoprotein CI stimulates the response to lipopolysaccharide and reduces mortality in gram-negative sepsis

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_15

High-density lipoprotein attenuates inflammation and coagulation response on endotoxin challenge in humans

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_15

Long pentraxin 3: experimental and clinical relevance in cardiovascular diseases

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_15

Multimer formation and ligand recognition by the long pentraxin PTX3. Similarities and differences with the short pentraxins C-reactive protein and serum amyloid P component.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_15

Pentraxin 3 protects from MCMV infection and reactivation through TLR sensing pathways leading to IRF3 activation

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_15

Expression of plasma platelet-activating factor acetylhydrolase is transcriptionally regulated by mediators of inflammation

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_15

High-Avidity Monoclonal Antibodies against the Human Scavenger Class B Type I Receptor Efficiently Block Hepatitis C Virus Infection in the Presence of High-Density Lipoprotein

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_15

Role of Scavenger Receptor Class B Type I in Hepatitis C Virus Entry: Kinetics and Molecular Determinants

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_15

Low serum level of high-density lipoprotein cholesterol is a poor prognostic factor for severe sepsis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_15

Endothelium-protective sphingosine-1-phosphate provided by HDL-associated apolipoprotein M

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_15

Assessment of cholesteryl ester transfer protein inhibitors for interaction with proteins involved in the immune response to infection

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_15

Host-derived oxidized phospholipids and HDL regulate innate immunity in human leprosy

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_15

The apolipoprotein A-I mimetic peptide 4F prevents defects in vascular function in endotoxemic rats

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_15

Characterization of hepatitis C virus particle subpopulations reveals multiple usage of the scavenger receptor BI for entry steps.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_15

HDL Mimetic Peptide Administration Improves Left Ventricular Filling and Cardiac output in Lipopolysaccharide-Treated Rats

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_15

The cell wall components peptidoglycan and lipoteichoic acid from Staphylococcus aureus act in synergy to cause shock and multiple organ failure

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_15

Inflammation modulates human HDL composition and function in vivo.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_15

Premature atherosclerosis in HIV-infected individuals--focus on protease inhibitor therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_15

PTX3 function as an opsonin for the dectin-1-dependent internalization of zymosan by macrophages

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_15

Cell-specific regulation of PTX3 by glucocorticoid hormones in hematopoietic and nonhematopoietic cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_15

Interactions of the humoral pattern recognition molecule PTX3 with the complement system

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_15

Receptor complementation and mutagenesis reveal SR-BI as an essential HCV entry factor and functionally imply its intra- and extra-cellular domains

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_15

Apolipoprotein L, a new human high density lipoprotein apolipoprotein expressed by the pancreas. Identification, cloning, characterization, and plasma distribution of apolipoprotein L

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_15

Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_15

The SR-BI partner PDZK1 facilitates hepatitis C virus entry.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_15

Paraoxonase activity in the serum and hepatic mRNA levels decrease during the acute phase response

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_15

Infection and inflammation decrease apolipoprotein M expression

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_15

ABC transporters, atherosclerosis and inflammation

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_15

Nevirapine increases high-density lipoprotein cholesterol concentration by stimulation of apolipoprotein A-I production

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_15

Non-redundant role of the long pentraxin PTX3 in anti-fungal innate immune response

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_15

Pentraxins at the crossroads between innate immunity, inflammation, matrix deposition, and female fertility

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_15

C-Reactive protein binds to apoptotic cells, protects the cells from assembly of the terminal complement components, and sustains an antiinflammatory innate immune response: implications for systemic autoimmunity

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_15

High density lipoprotein protects against polymicrobe-induced sepsis in mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_15

Inhibition of lipopolysaccharide-induced inflammatory responses by an apolipoprotein AI mimetic peptide.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_15

Neutralizing host responses in hepatitis C virus infection target viral entry at postbinding steps and membrane fusion.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_15

CD81 and Claudin 1 Coreceptor Association: Role in Hepatitis C Virus Entry

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_15

Contribution of the C-terminal end of apolipoprotein AI to neutralization of lipopolysaccharide endotoxic effect

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_15

Genetic causes of familial hypercholesterolaemia in patients in the UK: relation to plasma lipid levels and coronary heart disease risk

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_15

Regulation of adaptive immunity by the innate immune system

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_15

Endogenous PTX3 translocates at the membrane of late apoptotic human neutrophils and is involved in their engulfment by macrophages

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_15

Complexity and complementarity of outer membrane protein A recognition by cellular and humoral innate immunity receptors.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_15

Structural biology of the LPS recognition

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_15

Apolipoprotein A-I diminishes acute lung injury and sepsis in mice induced by lipoteichoic acid

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_15

HIV-1 infected patients with suppressed plasma viremia on treatment have pro-inflammatory HDL.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_15

Dysfunctional HDL and progression of atherosclerosis in HIV-1-infected and -uninfected adults

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_15

Effects of infection and inflammation on lipid and lipoprotein metabolism: mechanisms and consequences to the host

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_15

Functionally defective high-density lipoprotein: a new therapeutic target at the crossroads of dyslipidemia, inflammation, and atherosclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_15

Inhibition of hepatitis C virus infection by anti-claudin-1 antibodies is mediated by neutralization of E2-CD81-claudin-1 associations.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_15

Decreased plasma concentrations of apolipoprotein M in sepsis and systemic inflammatory response syndromes

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_15

4F, apolipoprotein AI mimetic peptide, attenuates acute lung injury and improves survival in endotoxemic rats.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_15

Serum amyloid A has antiviral activity against hepatitis C virus by inhibiting virus entry in a cell culture system

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_15

High-density lipoprotein prevents organ damage in endotoxemia

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_15

Distribution and kinetics of lipoprotein-bound lipoteichoic acid

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_15

High-density lipoprotein proteome dynamics in human endotoxemia.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_15

In vivo protection against endotoxin by plasma high density lipoprotein

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_15

Human ApoA-I overexpression diminishes LPS-induced systemic inflammation and multiple organ damage in mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_15

EGFR and EphA2 are host factors for hepatitis C virus entry and possible targets for antiviral therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_15

HIV therapies and atherosclerosis: answers or questions?

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_15

The interaction of natural hepatitis C virus with human scavenger receptor SR-BI/Cla1 is mediated by ApoB-containing lipoproteins.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_15

Hepatitis C virus production requires apolipoprotein A-I and affects its association with nascent low-density lipoproteins

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_15

Inflammation impairs reverse cholesterol transport in vivo.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_15

A human monoclonal antibody targeting scavenger receptor class B type I precludes hepatitis C virus infection and viral spread in vitro and in vivo

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_15

Human immunodeficiency virus impairs reverse cholesterol transport from macrophages

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_15

Mutation of the ATP cassette binding transporter A1 (ABCA1) C-terminus disrupts HIV-1 Nef binding but does not block the Nef enhancement of ABCA1 protein degradation

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_15

Lipoproteins in inflammation and sepsis. I. Basic science

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_15

Neutrophil Activation Is Attenuated by High-Density Lipoprotein and Apolipoprotein A-I in In Vitro and In Vivo Models of Inflammation

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_15

Biochemical and functional characterization of the interaction between pentraxin 3 and C1q.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_15

The oxidation hypothesis of atherogenesis: the role of oxidized phospholipids and HDL.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_15

Association between Hepatitis C Virus and Very-Low-Density Lipoprotein (VLDL)/LDL Analyzed in Iodixanol Density Gradients

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_15

High-density lipoproteins induce transforming growth factor-beta2 expression in endothelial cells.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_15

Modified HDL: biological and physiopathological consequences.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_15

Long pentraxin 3, a key component of innate immunity, is modulated by high-density lipoproteins in endothelial cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_15

Deficiency of the Long Pentraxin PTX3 Promotes Vascular Inflammation and Atherosclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_15

The long pentraxin PTX3: a modulator of the immunoinflammatory response in atherosclerosis and cardiovascular diseases.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_15

HDLs, immunity, and atherosclerosis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_15

Emerging role of high density lipoproteins as a player in the immune system.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_15

Antiinflammatory effects of reconstituted high-density lipoprotein during human endotoxemia

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_15

APOL1 risk variants, race, and progression of chronic kidney disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_15

Effect of efavirenz on high-density lipoprotein antioxidant properties in HIV-infected patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_15

Apolipoprotein L-I promotes trypanosome lysis by forming pores in lysosomal membranes

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_15

Treating high density lipoprotein cholesterol (HDL-C): quantity versus quality

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_15

Human occludin is a hepatitis C virus entry factor required for infection of mouse cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_15

Molecular mechanisms of late apoptotic/necrotic cell clearance

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_15

Antiviral activity of the long chain pentraxin PTX3 against influenza viruses

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_15

Impact of HIV infection and HAART on serum lipids in men.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_15

HIV infection and high-density lipoprotein: the effect of the disease vs the effect of treatment.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_15

HIV infection and high density lipoprotein metabolism

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_15

Interaction of C1q with IgG1, C-reactive protein and pentraxin 3: mutational studies using recombinant globular head modules of human C1q A, B, and C chains

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_15

High density lipoproteins and atherosclerosis: emerging aspects.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_15

Prevalence of classical CD14++/CD16- but not of intermediate CD14++/CD16+ monocytes in hypoalphalipoproteinemia.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_15

Trypanosome lytic factor, an antimicrobial high-density lipoprotein, ameliorates Leishmania infection

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_15

The human scavenger receptor class B type I is a novel candidate receptor for the hepatitis C virus

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_15

Apolipoprotein A-I mimetic peptides: a potential new therapy for the prevention of atherosclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_15

Hypocholesterolemia is associated with immune dysfunction in early human immunodeficiency virus-1 infection

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_15

Antiviral effects of apolipoprotein A-I and its synthetic amphipathic peptide analogs

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_15

High-density lipoprotein suppresses the type I interferon response, a family of potent antiviral immunoregulators, in macrophages challenged with lipopolysaccharide

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_15

Small molecule scavenger receptor BI antagonists are potent HCV entry inhibitors

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_15

Native high-density lipoprotein augments monocyte responses to lipopolysaccharide (LPS) by suppressing the inhibitory activity of LPS-binding protein

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_15

Association of hepatitis C virus in human sera with beta-lipoprotein

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_15

New function for high density lipoproteins. Their participation in intravascular reactions of bacterial lipopolysaccharides

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_15

New function for high density lipoproteins. Isolation and characterization of a bacterial lipopolysaccharide-high density lipoprotein complex formed in rabbit plasma

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_15

Receptors, mediators, and mechanisms involved in bacterial sepsis and septic shock

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_15

Lipoprotein metabolism in patients with severe sepsis

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_15

The prototypic tissue pentraxin PTX3, in contrast to the short pentraxin serum amyloid P, inhibits phagocytosis of late apoptotic neutrophils by macrophages

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_15

Apolipoprotein L-I is the trypanosome lytic factor of human serum

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_15

Binding and internalization of lipopolysaccharide by Cla-1, a human orthologue of rodent scavenger receptor B1

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_15

High density lipoproteins facilitate hepatitis C virus entry through the scavenger receptor class B type I.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_15

Oxidized low-density lipoprotein inhibits hepatitis C virus cell entry in human hepatoma cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_15

Lipoproteins in inflammation and sepsis. II. Clinical aspects.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_15

The trypanolytic factor-mechanism, impacts and applications.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_15

Apolipoprotein M is required for prebeta-HDL formation and cholesterol efflux to HDL and protects against atherosclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_15

The postbinding activity of scavenger receptor class B type I mediates initiation of hepatitis C virus infection and viral dissemination

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_15

Scavenger receptor class B type I is a key host factor for hepatitis C virus infection required for an entry step closely linked to CD81.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_15

Hepatitis C virus entry into hepatocytes: molecular mechanisms and targets for antiviral therapies

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_15

10.1007/978-3-319-09665-0_15

31 March 2020

Identifiers

DOI

1 reference

1 September 2017

1 reference

PubMed ID

25522999